| Literature DB >> 26464977 |
Abstract
Light has long been known to modulate sleep, but recent discoveries support its use as an effective nocturnal stimulus for eliciting sleep in certain rodents. "Photosomnolence" is mediated by classical and ganglion cell photoreceptors and occurs despite the ongoing high levels of locomotion at the time of stimulus onset. Brief photic stimuli trigger rapid locomotor suppression, sleep, and a large drop in core body temperature (Tc; Phase 1), followed by a relatively fixed duration interval of sleep (Phase 2) and recovery (Phase 3) to pre-sleep activity levels. Additional light can lengthen Phase 2. Potential retinal pathways through which the sleep system might be light-activated are described and the potential roles of orexin (hypocretin) and melanin-concentrating hormone are discussed. The visual input route is a practical avenue to follow in pursuit of the neural circuitry and mechanisms governing sleep and arousal in small nocturnal mammals and the organizational principles may be similar in diurnal humans. Photosomnolence studies are likely to be particularly advantageous because the timing of sleep is largely under experimenter control. Sleep can now be effectively studied using uncomplicated, nonintrusive methods with behavior evaluation software tools; surgery for EEG electrode placement is avoidable. The research protocol for light-induced sleep is easily implemented and useful for assessing the effects of experimental manipulations on the sleep induction pathway. Moreover, the experimental designs and associated results benefit from a substantial amount of existing neuroanatomical and pharmacological literature that provides a solid framework guiding the conduct and interpretation of future investigations.Entities:
Keywords: circadian; masking; melanin-concentrating hormone; melanopsin; orexin; sleep
Year: 2015 PMID: 26464977 PMCID: PMC4596090 DOI: 10.1523/ENEURO.0069-14.2015
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822
Figure 1.Simultaneously recorded patterns of wheel running (RPM; black solid lines) and core body temperature (red broken lines) in three individual mice housed under LD12:12 and, during the night the data were collected, exposed at ZT13 (time 0 is stimulus onset) to a 5 min light pulse (, , narrow white area) and a 1 h light pulse (, broad white area). The arrowheads in and indicate portions of the records during which Tc has risen in advance of recovered locomotion. The asterisk in identifies a rise in Tc and an aborted return to normal. Despite the increase in Tc, the simultaneously recorded wheel running does not correspondingly increase from its level of complete suppression during light exposure. After Figure 3 in Studholme et al. (2013).
Figure 2.Wheel running rate by non-photostimulated mice (CON; ); mice that received 10 light flashes, 2 ms each, with 30 s interflash intervals (IFI; ); and mice that received a single 5 min light pulse (). Photic stimulation began at time 0. The filled squares/red dotted line indicates the behavior of mice lacking melanopsin (OPN4−/−). The rd/rd mice (open triangles/green dashed line) lack rods or cones. WT, Wild-type controls (filled circles/black solid line). In and , the OPN4−/− mice show a rapid locomotor suppression effect that is soon followed by erratic levels of locomotion, rather than the typical complete suppression seen in WT and rd/rd mice. After Figure 3 in Morin and Studholme (2011).
Figure 3., Retinal projections, retinorecipient nuclei, and second order afferents to the VLPO. Black pathways, First-order retinal projections to basal forebrain, thalamic, and visual midbrain nuclei (thick black outlines in both and ). Red pathways, Second-order projections afferent to the VLPO from retinorecipient nuclei. Projection density roughly corresponds to arrow line thickness. , Connections between forebrain nuclei that may be providing second- or third-order retinal input to the sleep regulatory system. Solid red pathways, Virally traced projections from the SCN with at least one known synapse (red circles). Broken red pathways, Possible routes from the SCN to the VLPO involving a probable, but not identified, synapse (large broken red circles). Solid black pathways, Projections to ORx cells (after Yoshida et al., 2006; there is no similar information for MCH cell innervation). Dotted black pathways, Other projections to and from sleep-regulatory nuclei. Note: All nuclei identified in the figure are innervated by both ORx and MCH cells (see Table 1). See Table 2 for anatomical abbreviations and the text for references. These schematics are not intended to exclude any other possible arrangement of connections between the visual and sleep systems.
Retinorecipiency of selected brain regions and their innervation by orexin or MCH cells
| Brain region | Retinal input | Orexin terminals | MCH terminals |
| Sleep/circadian-related | |||
| DM | – | ++++ | +++ |
| DPGi | – | ++ | +++ |
| DR | – | ++++ | +++ |
| IGL | ++++ | ++++ | ++ |
| LC | – | +++++ | ++ |
| LDTg | – | + | ++ |
| LDTgV | – | + | ++ |
| MnR | – | ++++ | +++ |
| MPA | ± | +++ | ++ |
| MPO | – | +++ | ++ |
| MTu | – | +++ | ++++ |
| OPT | ++++ | – | ++ |
| PNo | – | + | ++ |
| PPTg | – | ++ | +++ |
| SCN | +++++ | + | ++ |
| SubCA | – | + | +++ |
| VLPO | ± | + | + |
| VTA | – | + | +++ |
| Other retinorecipient | |||
| CPT | +++ | +++ | ++ |
| DLG | +++++ | – | ++ |
| HDB | + | ++ | ++++ |
| InG | +++ | + | ++ |
| MeA | + | +++ | + |
| MT | +++++ | – | ++ |
| Op | +++++ | + | ++ |
| PHb | +++ | + | ++ |
| PLi | ++ | ++ | ++ |
| RCh | ++ | ++++ | ++ |
| sPA | ++ | +++ | ++ |
| SuG | +++++ | – | +++ |
| Zo | +++++ | – | + |
Estimated density: extremely dense +++++; dense ++++; moderate +++; modest ++; sparse +; very sparse ±; none –.
From Table 1 in Morin and Studholme (2014b)
Hamster data from Table 1 in Mintz et al. (2001) and Table 1 in Horowitz et al. (2005) with reference to corresponding photomicrographs to resolve nomenclature ambiguities between Mintz et al. and Horowitz et al.
Rat data from Table 2 in Bittencourt et al. (1992) or reference to corresponding photomicrographs to resolve nomenclature ambiguities.
New data from direct examination of archived hamster tissue (Morin and Blanchard, unpublished observations).
Hamster data from Vidal et al. (2005).
Anatomical abbreviations
| AH | anterior hypothalamic nucleus |
| CPT | commissural pretectal nucleus |
| DLG | dorsolateral geniculate nucleus |
| DM | dorsomedial hypothalamic nucleus |
| DPGi | dorsal paragigantocellular nucleus |
| DR | dorsal raphe nucleus |
| HDB | diagonal band nucleus, horizontal limb |
| IGL | intergeniculate leaflet |
| InG | intermediate gray layer, superior colliculus |
| LA | lateroanterior hypothalamic nucleus |
| LC | locus coeruleus |
| LDTg | lateral dorsal tegmental nucleus |
| LDTgV | lateral dorsal tegmental nucleus, ventral |
| LPBC | lateral parabrachial nucleus, central part |
| MeA | medial amygdala nucleus, anterior |
| MnR | median raphe nucleus |
| MPA | medial preoptic area |
| MPO | medial preoptic nucleus |
| MT | medial terminal nucleus |
| MTu | medial tuberal hypothalamic nucleus |
| Op | optic layer, superior colliculus |
| OPT | olivary pretectal nucleus |
| Pa | paraventricular hypothalamic nucleus |
| PHb | parahabenular area |
| PLi | posterior limitans nucleus |
| PNo | pontine reticular nucleus, oral part |
| PP | peripeduncular nucleus |
| PPTg | pedunculopontine tegmental nucleus |
| pSON | peri-supraoptic area |
| RCh | retrochiasmatic area |
| SCN | suprachiasmatic nucleus |
| SON | supraoptic nucleus |
| sPa | subparaventricular hypothalamic nucleus |
| SubCA | subcoerulean area |
| SuG | superficial gray layer, superior colliculus |
| VLG | ventrolateral geniculate nucleus |
| VLPO | ventrolateral preoptic nucleus |
| VTA | ventral tegmental area |
| ZI | zona incerta |
| Zo | zonal layer, superior colliculus |
Figure 4.Mean simultaneously recorded activity indices (solid black lines; motion detected from video) and core body temperatures (broken red lines) for groups of mice injected with vehicle (VEH; , ), methamphetamine (MA; ), modafinil (MOD; ), caffeine (CAF; , ), 20 and 40 mg, respectively. The times of injection are indicated by the arrowhead and broken vertical line. The daylight period (white area) is to the left and dark period is to the right (shaded area). In , no light pulse was administered. In , a 5 min light pulse (vertical white area) began at time 0. The light-induced drop in mean locomotor activity and Tc is evident in (double-headed arrow) and less so in . Modified from Figures 5-7 in Vivanco et al. (2013); see for details.